UroStream

At hashtag#EAU25, Prof. Shousheng Chen (陈守臻) from Qilu Hospital of Shandong University shared key findings from his study on a "biopsy-free" diagnostic approach for prostate cancer using PSMA PET/CT, mpMRI, and serum biomarkers. He discussed how this strategy compares with traditional PSA and DRE, its potential in early diagnosis, and how it could guide follow-up and monitoring.

At hashtag#EAU25 in Madrid, we had the opportunity to interview Professor Liangyou Gu from the General Hospital of the Chinese PLA, who shared his clinical perspective on emerging treatment strategies for muscle-invasive bladder cancer (MIBC). With ongoing breakthroughs in MIBC research, bladder-sparing approaches are gaining traction alongside radical cystectomy. Prof. Gu offered his insights on how clinicians can evaluate the best option for each patient, especially in the context of neoadjuvant therapy.

At the 40th Annual European Association of Urology (EAU) Congress, precision biopsy strategies and technological innovation were core topics in the prostate cancer field. With a focus on addressing the limitations of traditional systematic biopsies and MRI-targeted biopsies, multiple studies concentrated on optimizing biopsy approaches to balance diagnostic efficacy and safety. "UroStream" invited Professors Kan Gong and Yi Liu from Peking University First Hospital, along with Dr. Ruiyi Deng, to discuss the latest advancements in prostate cancer biopsy at the EAU conference, their team’s peri-lesion biopsy RCT study findings, and cutting-edge precision biopsy approaches.

Published in Breast Cancer (Springer) in June 2024,Sujata Purja, Dung Thuy Nguyen, and Eunyong Kim provide a comprehensive analysis of the evolving landscape of breast cancer epigenetics, emphasizing the therapeutic…

At EAU25, Professor Alexander Mottrie presented the latest real-world findings from one of the largest prospective series evaluating the Hugo™ Robotic-Assisted Surgery (RAS) System in urology. This international study, conducted…

At #EAU25, Dr. Rodrigo Ledezma and colleagues presented the first-in-human results from the ASTRA study, evaluating robotic-assisted Holmium Laser Enucleation of the Prostate (RoLEP) using the Beacon Platform.This novel robotic…

At EAU25, Dr. Francesco Pellegrino from IRCCS San Raffaele Scientific Institute presented a crucial analysis on the generalizability of randomized trials in newly diagnosed metastatic prostate cancer (mPCa). Using the…

Presented by Dr. Kari Tikkinen and team at EAU25, the APPEAL trial is the largest randomized controlled study to date evaluating the role of antimicrobial prophylaxis during shock wave lithotripsy…

Presented by Dr. Trinity Bivalacqua at EAU25, the BOND-003 Phase 3 trial showcases updated data on intravesical cretostimogene grenadenorepvec, an innovative oncolytic immunotherapy for patients with high-risk BCG-unresponsive non–muscle invasive…